tirzepatide shortage news today is NO longer in SHORTAGE. What You Need to Know FDA declares Mounjaro, Zepbound shortage

Many aspects of MeDiet 3-PUFAs, including their antioxidant and anti-inflammatory properties and various mechanisms of action behind their anti-inflammatory activity, are beneficial in the prevention and/or treatment of PD (7, 114, 115)

dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

And in some cases, it might mean switching from tirzepatide to semaglutide or vice versa

Key Benefits Contains glutathione, CoQ10, and PQQ